Abstract:Targeted anticancer drugs block cancer cell growth by interfering with specific signaling pathways vital to carcinogenesis and tumor growth rather than harming all rapidly dividing cells as in cytotoxic chemotherapy. The Response Evaluation Criteria in Solid Tumor (RECIST) system has been used to assess tumor response to therapy via changes in the size of target lesions as measured by calipers, conventional anatomically based imaging modalities such as computed tomography (CT), and magnetic resonance imaging (MRI), and other imaging methods. However, RECIST is sometimes inaccurate in assessing the efficacy of targeted therapy drugs because of the poor correlation between tumor size and treatment-induced tumor necrosis or shrinkage. This approach might also result in delayed identification of response when the therapy does confer a reduction in tumor size. Innovative molecular imaging techniques have rapidly gained importance in the dawning era of targeted therapy as they can visualize, characterize, and quantify biological processes at the cellular, subcellular, or even molecular level rather than at the anatomical level. This review summarizes different targeted cell signaling pathways, various molecular imaging techniques, and developed probes. Moreover, the application of molecular imaging for evaluating treatment response and related clinical outcome is also systematically outlined. In the future, more attention should be paid to promoting the clinical translation of molecular imaging in evaluating the sensitivity to targeted therapy with biocompatible probes. In particular, multimodal imaging technologies incorporating advanced artificial intelligence should be developed to comprehensively and accurately assess cancer-targeted therapy, in addition to RECIST-based methods.

Molecular-targeted Therapy for Cancer

Research Progress in the Mechanism of Molecular Targeted Anti-tumor Drugs

Molecular targeted therapy: Treating cancer with specificity

Molecular Targeted Therapy of Cancer: the Progress and Future Prospect

Molecular targeted therapy for anticancer treatment

Advances in Molecularly Targeted Cancer Therapy

Research advances of targeted therapy of cancer

Advances on Molecular Targeted Anti-Tumor Drugs

Targeted therapy and precision medicine for lung cancer

Molecular Target Therapy: a Milestone on the Road for Curing Cancer

Molecular-targeted agents combination therapy for cancer: developments and potentials

Role of Small Molecule Targeted Compounds in Cancer: Progress, Opportunities, and Challenges

Molecularly targeted cancer therapy: some lessons from the past decade

Small molecules in targeted cancer therapy: advances, challenges, and future perspectives

Overview of molecular diagnosis and targeted treatment of tumor

Molecular-targeted therapy of pancreatic carcinoma and its progress

Receptor-Targeted Cancer Therapy

Molecular and functional imaging in cancer-targeted therapy: current applications and future directions

Molecular targeted therapy for the treatment of gastric cancer

Targeting Tumor Suppressor Genes for Cancer Therapy

Targeted Biopharmaceuticals for Cancer Treatment